{
    "answer": "2024 Cosentyx Net Sales: USD 6.1 billion (reported +22%, constant currency +24%). 2023 Cosentyx Reported Net Sales (immunology segment) deducted Xolair sales: USD 1,303 million (FY +21%, US sales +21%). Full year 2023 (immunology segment) Segment Revenue: $13.0 billion.",
    "ground_truth": "$6,141,000,000; 23% increase (reported); 25% increase (constant currency)",
    "rewards": [
        0,
        0,
        0,
        0,
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 7,
    "search count": 6,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        935,
        2816,
        4503,
        5888,
        7442,
        9012,
        10650
    ]
}